• DOI:10.1586/14779072.5.1.9
Corpus ID: 11255636

Dofetilide: a new class III antiarrhythmic agent

@article{Roukoz2007DofetilideAN,
  title={Dofetilide: a new class III antiarrhythmic agent},
  author={H. Roukoz and W. Saliba},
  journal={Expert Review of Cardiovascular Therapy},
  year={2007},
  volume={5},
  pages={19 - 9}
}

H. Roukoz, W. Saliba

Published 2007

Medicine

Expert Review of Cardiovascular Therapy

Dofetilide is a relatively new class III antiarrhythmic agent that selectively blocks the rapid component of the cardiac ion channel delayed rectifier current. This results in an increase in the action potential duration and effective refractory period of the myocyte, thereby terminating reentrant tachyarrhythmias and preventing their re-induction. Oral dofetilide is effective in the conversion of atrial fibrillation and flutter to sinus rhythm and in the maintenance of sinus rhythm after… CONTINUE READING

View on Taylor & Francis

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed